Research Article
IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study
Table 2
IRS1 in leukocytes and liver of patients with hepatitis C virus and their correlation.
| Variable | IRS1 leukocytes | IRS1 liver | () | () | Value | Spearman (rho) | | Value | Spearman (rho) | |
| Age | 44.77 | −0.368 | 0.02 | 44.89 | −0.297 | 0.07 | (mean ± SD) | (±8.4) | (±7.9) | HOMA-IR | 2.63 | −0.118 | 0.55 | 2.13 | −0.341 | 0.04 | (median 25th–75th%) | (1.38–3.86) | (1.28–3.90) | HCV viral load | 1119,225 | 0.291 | 0.16 | 807,000 | −0.135 | 0.44 | (median 25th–75th%) | (518,280–3107,865) | (310,000–3101,797) | Fibrosis | F3—2 (6.9%) | −0.022 | 0.91 | F3—3 (8.1%) | −0.182 | 0.28 | (%) | F1,2—27 (93.1%) | F1,2—34 (91.9%) | Fibrosis progression | 0,0006876 | −0.030 | 0.87 | 0,0006876 | −0.187 | 0.28 | (median 25th–75th%) | (0.0005–0.00100) | (0.0005–0.00100) |
|
|